Understanding Your Laboratory Test: What It Is, How It Is Done, and What Your Results Mean
A blood test that detects IgG antibodies targeting nucleoli (parts of the cell nucleus) to help diagnose autoimmune diseases.
{"Detects antibodies against nucleolar proteins in the blood","Helps diagnose autoimmune conditions like systemic sclerosis","Performed using immunofluorescence on a blood serum sample","Results are reported as a titer (dilution level)","Often ordered along with other autoimmune tests"}
Key facts at a glance
- LOINC
- 85080-0
- Short code
- ANA IgG nucleolar Titr Ser IF
- Synonyms
- ANA IgG nucleolar Titr Ser IF
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- if
- CPT
- 86038
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
This test is a laboratory analysis that helps your healthcare provider evaluate your overall health and screen for or monitor certain medical conditions. It measures specific substances in your body, and the results give your care team important information to guide diagnosis, treatment decisions, and ongoing follow-up care.
The Nucleolar IgG Antibody Test is a specialized blood test that looks for IgG antibodies that target structures called nucleoli inside the cell nucleus. Nucleoli are small, dense structures within the nucleus that play a role in producing ribosomes (the cell's protein-making machinery). When the immune system mistakenly produces antibodies against these structures, it can indicate an autoimmune disease.
The test is usually performed by drawing a small sample of blood from a vein in your arm, although some tests use urine, saliva, or a simple swab instead. A trained technician cleans the site, collects the sample, and sends it to a laboratory for analysis. The procedure is quick, typically takes only a few minutes, and causes little more than brief discomfort.
A healthcare professional will draw a small blood sample from a vein in your arm. The blood is then sent to a laboratory where it undergoes immunofluorescence testing. In this technique, the serum (the liquid part of blood) is mixed with special fluorescent dyes and examined under a microscope. If nucleolar IgG antibodies are present, they will bind to the nucleoli and glow (fluoresce) under specific light wavelengths. The test results are reported as a titer, which indicates the highest dilution of your blood serum where antibodies can still be detected.
Your results show whether the measured values fall within the normal reference range for your age and sex. Values that are higher or lower than expected may point to an infection, a nutritional deficiency, a chronic condition, or another issue that needs attention. Your healthcare provider will review the findings with you, explain what they mean in your situation, and recommend any next steps, such as repeat testing, additional tests, or a treatment plan.
A positive result means that nucleolar IgG antibodies were detected in your blood. The titer level indicates how concentrated these antibodies are—higher titers typically suggest more significant immune activity. However, the interpretation of your results should be done by your healthcare provider, who will consider your symptoms, medical history, and results from other tests.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The nucleolar IgG pattern is primarily associated with systemic sclerosis (also known as scleroderma), a chronic autoimmune disease that affects the skin and internal organs. The presence of nucleolar antibodies, particularly with a high titer, strongly suggests systemic sclerosis. These antibodies are found in approximately 20-30% of patients with systemic sclerosis.
However, nucleolar antibodies can also be present in other autoimmune conditions, including Sjögren's syndrome, systemic lupus erythematosus (SLE), polymyositis, and dermatomyositis. Therefore, this test is usually not used alone for diagnosis but is combined with other antibody tests (such as anti-Scl-70, anti-centromere, and ANA) and clinical evaluation.
Your healthcare provider will interpret your results in the context of your overall clinical picture. A positive result helps confirm the diagnosis and may guide treatment decisions, while a negative result does not completely rule out autoimmune disease if symptoms are present.
Frequently asked questions
Do I need to fast before this test?
Are there any risks associated with this test?
How long does it take to get results?
Can medications affect my test results?
What happens if my test is positive?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy